Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
National Institute of Allergy and Infectious Diseases (NIAID)
Raphael J Landovitz; Deborah Donnell; Meredith E Clement; Brett Hanscom; Leslie Cottle; Lara Coelho; Robinson Cabello; Suwat Chariyalertsak; Eileen F Dunne; Ian Frank; Jorge A Gallardo-Cartagena; Aditya H Gaur; Pedro Gonzales; Ha V Tran; Juan C Hinojosa; Esper G Kallas; Colleen F Kelley; Marcelo H Losso; J Valdez Madruga; Keren Middelkoop; Nittaya Phanuphak; Breno Santos; Omar Sued; Javier Valencia Huamaní; Edgar T Overton; Shobha Swaminathan; Carlos Del Rio; Roy M Gulick; Paul Richardson; Philip Sullivan; Estelle Piwowar-Manning; Mark Marzinke; Craig Hendrix; Maoji Li; Zhe Wang; Jeanne Marrazzo; Eric Daar; Aida Asmelash; Todd T Brown; Peter Anderson; Susan H Eshleman; Marcus Bryan; Cheryl Blanchette; Jonathan Lucas; Christina Psaros; Steven Safren; Jeremy Sugarman; Hyman Scott; Joseph J Eron; Sheldon D Fields; Nirupama D Sista; Kailazarid Gomez-Feliciano; Andrea Jennings; Ryan M Kofron; Timothy H Holtz; Katherine Shin; James F Rooney; Kimberly Y Smith; William Spreen; David Margolis; Alex Rinehart; Adeola Adeyeye; Myron S Cohen; Marybeth McCauley; Beatriz Grinsztejn; HPTN 083 Study Team